switching to semaglutide from tirzepatide vs. Semaglutide: What You Should Know Switching from Semaglutide to Tirzepatide

Clinical trials confirm that monotherapy (4.5 mg weekly subcutaneous injection) reduces body weight by 10.8% in obese patients (BMI 30) over 26 weeks, significantly outperforming placebo [4]

J Biol Chem 288:67886800 Lodhiya T, Palande A, Veeram A, Larrouy-Maumus G, Beste DJV, Mukherjee R (2026) ATP burst is the dominant driver of antibiotic lethality in Mycobacterium smegmatis

The influences of diet and exercise on mental health through hormesis

Need to activate your Subscription

Under the new deal, Americans will be able to buy Wegovy and Zepbound for $350 a month directly from manufacturers or TrumpRx.gov, a new site launching in January 2026